Carsten Tschöpe Profile Page
| Organisation: | Charité |
| Department: | Medical Clinic for Cardiology and Pulmology |
| Address: | Hindenburgdamm 30 12200 Berlin |
| Campus: | Benjamin Franklin |
| E-Mail: | This e-mail address is being protected from spam bots, you need JavaScript enabled to view it |
| Field: | Cardiovascular System |
| Track(s): | Med |
| CV: | 2004 Senior Resident, Dept. of Cardiology, Charite Campus Benjamin Franklin, Berlin; Specialist for Internal Medicine. 2003 University lecturer qualification: Diabetic cardiopathy 2002 Medical Specialist in Internal Medicine 1996-present Group Leader “Experimental Cardiology” and Fellow of the Dept. of Cardiology Charité Campus Benjamin Franklin, Berlin 1995-1996 Fellowship, Dept. of Pharmacology, University of Kiel 1993-1995 Fellowship, Dept. of Nephrology, University of Heidelberg 1993 Doctoral thesis at the Institute of Pharmacology, Heidelberg University 1992 Study of Medicine, University of Montreal 1986-1993 Study of Medicine, University of Heidelberg |
| Research Interests: | main field: inflammatory cardiomyopathy, diabetic cardiopathy, ischemic cardiopathy other fields: diastolic dysfunction, endothelial dysfunction, peptide systems current research interest: experimental and clinical studies in cardiology, stem cells |
| Publications: | Riad A, Unger D, Du J, Westermann D, Mohr Z, Sobirey M, Dorenkamp M, Schultheiss HP,Tschöpe C (2006) Chronic Inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitus. Eur J Pharm: in press Tschöpe C, Bock CT, Kasner M, Noutsias M, Westermann D, Schwimmbeck PL, Pauschinger M, Poller WC, Kühl U, Kandolf R, Schultheiss H-P (2005) High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111: 879-886 Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschöpe C 2005 Protective role of angiopoietin-1 in endotoxic Shock. Circulation 111: 97-105 Tschöpe C, Spillmann F, Rehfeld U, Koch M, Westermann D, Altmann C, Dendorfer A, Walther T, Bader M, Paul M, Schultheiss HP, Vetter R (2004) Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene. FASEB J 18: 1967-1969 Tschöpe C, Walther T, Königer J, Spillmann F, Westermann D, Escher F, Pauschinger M, Pesquero JB, Bader M, Schultheiss HP, Noutsias M (2004) Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. FASEB J 18: 828-835 Tschöpe C, Spillmann F, Altmann C. , Koch M, Westermann D, Dhayat N, Dhayat S, Bascands JL, Gera L, Hoffmann S, Schultheiss HP, Walther T (2004) Bradykinin B1 receptor is a mediator of the cardio-protective effects of AT1 blockade after myocardial infarction. Cardiovasc Res 61: 559-569 Fechner H, Noutsias M, Tschöpe C, Hinze K, Wang X, Escher F, Dekkers D, Lamers J, Vetter R, Paul M, Pauschinger M, Schultheiss HP, Poller WC (2003) Regulation of Coxsackie-adenovirus-receptor expression during myocardial tissue formation and remodeling - Evidence of cell-cell contact dependent regulation. Circulation 107: 876-882 Walther T, Siems W-E, Hauke D, Spillmann F, Dendorfer A, Krause W, Schultheiss HP, Tschöpe C (2002) AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats. FASEB J 16: 1237-1241 Vetter R, Rehfeld U, Reissfelder C, Weiss W, Wagner KD, Gunther J, Hammes A, Tschöpe C, Dillmann W, Paul M (2002) Transgenic overexpression of the sarcoplasmic reticulum Ca2+ATPase improves reticular Ca2+ handling in normal and diabetic rat hearts. FASEB J 16: 1657-1659 Tschöpe C, Gohlke P, Walther T, Unger Th (2000) The angiotensin Type 2 receptor and the kallikrein-kinin system: is there a link? In: Hypertension and hypertension-related organ damage: an update in the year 2000, published by Churchill-Livingstone/Momento Medico: 11-26 |
